ZTEK Zentek Ltd.
Price Chart
Executive Summary
Zentek closed a fully-subscribed brokered LIFE offering for gross proceeds of C$18M (18M units at C$1.00/unit), with each unit comprising one common share and a five-year warrant exercisable at C$1.50. Proceeds are earmarked for Albany Graphite project development (PEA, feasibility studies), ZenGUARD commercialization, and working capital. The offering represents ~28% dilution to the pre-offering share count (~65M shares outstanding implied by $65M market cap at ~$1.00/share), plus additional warrant overhang.
Actionable Insight
Warrant overhang (19.2M total, vs 18M shares issued) will cap upside and pressure the stock toward the C$1.00 offering level near-term. Monitor for TSXV final approval and potential secondary share pressure as freely-tradable units enter the market (Canadian purchasers' shares and warrants are immediately tradable). Catalyst potential from Albany PEA (summer 2026) and ZenGUARD pilot are long-dated; near-term price action likely driven by dilution absorption and warrant delta hedging.
Key Facts
- Gross proceeds raised: C$18M via 18M units at C$1.00/unit
- Each unit: 1 common share + 1 warrant (C$1.50 exercise, 5-year term, exp. May 27, 2029)
- Warrant overhang: 18M common shares + 1.197M broker warrants exercisable at C$1.00
- Insiders purchased 695,000 units (3.9% of offering); subject to hold period until Sep 28, 2026
- Broker (Red Cloud) received C$1.197M cash fee and 1.197M broker warrants
- Offering price (C$1.00) represents ~100% of pre-offering market price (implied ~$1.00/share from $65M cap)
- Use of proceeds: Albany Graphite PEA & feasibility, ZenGUARD commercialization, working capital
- Closing is 6 days after the Offering Document date (May 14); shares not registered under US Securities Act
- Filing type: 6-K (foreign private issuer report) with cross-filing amplifier verdicts for activist/offering/annual context
Financial Impact
~28% dilution from 18M new shares against ~65M pre-offering float; total share count pro forma ~83M, plus 19.2M total warrants (18M unit warrants + 1.2M broker warrants) creating ~23% additional overhang if exercised
Risk Factors
- Near-term price pressure from ~28% dilutive share issuance plus 19.2M warrant overhang
- Warrants exercisable at C$1.50 (50% premium) limit upside; unlikely to be exercised near-term
- Company has no current revenue generation; reliance on future development milestones for value creation
- TSXV final approval still pending, creating residual execution risk
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001062993-26-002893 |
| Document: form6k.htm | 0001062993-26-002893 |
| Document: 0001062993-26-002893-index-headers.html | 0001062993-26-002893 |
| Document: 0001062993-26-002893-index.html | 0001062993-26-002893 |
| Document: 0001062993-26-002893.txt | 0001062993-26-002893 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 9, 2026
11d ago
|
6-K
| $0.4779 $0.4320 | ▼ −9.60% | ▼ −12.02% | $0.4100 (−14.21%) |
|
May 27, 2026
24d ago
|
6-K
| $0.5900 $0.5600 | ▲ +5.08% | ▲ +6.29% | $0.4100 (+30.51%) |
|
May 13, 2026
5w ago
|
6-K
| $1.01 $0.7300 | ▼ −27.72% | ▼ −26.56% | $0.4100 (−59.41%) |
|
Apr 28, 2026
7w ago
|
6-K
| $0.4500 $0.5000 | ▲ +11.11% | ▲ +9.42% | $0.4100 (−8.89%) |
|
Apr 22, 2026
8w ago
|
6-K
| $0.5000 $0.4315 | ▼ −13.70% | ▼ −13.75% | $0.4100 (−18.00%) |
|
Apr 16, 2026
9w ago
|
6-K
| $0.4900 $0.4700 | ▼ −4.08% | ▼ −4.64% | $0.4100 (−16.33%) |
|
Apr 15, 2026
9w ago
|
6-K
| $0.4800 $0.5000 | ▲ +4.17% | ▲ +2.53% | $0.4100 (−14.58%) |
|
Apr 13, 2026
9w ago
|
6-K
| $0.5400 $0.5000 | ▼ −7.41% | ▼ −10.70% | $0.4100 (−24.07%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access